Literature DB >> 10695658

Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients.

H Nakamura1, A Kawakami, M Tominaga, A Hida, S Yamasaki, K Migita, Y Kawabe, T Nakamura, K Eguchi.   

Abstract

We have previously demonstrated a high prevalence of Sjögren's syndrome (SS) in patients with human T-lymphotropic virus type I-associated myelopathy (HAM) in Nagasaki prefecture. The present follow-up study compared the clinical and laboratory findings of SS with or without human T-lymphotropic virus type I (HTLV-I) antibody in this endemic area for HTLV-I infection. We investigated the clinical and laboratory manifestations in 83 patients with SS and HAM, including histologic examination of labial salivary glands and the prevalence of SS in patients with HAM. Definite SS was diagnosed in 13 out of 20 patients with HAM when the European Community criteria were used. The density of mononuclear cell infiltration in labial salivary glands was higher in HTLV-I-seropositive patients with SS (including patients with HAM) than in HTLV-I-seronegative patients. The volume of saliva and lacrima determined by the Schirmer or Saxon test was lower than normal but was not different among SS-HTLV-I-seronegative patients, HTLV-I-seropositive patients without HAM, and HTLV-I-seropositive patients with HAM. The proportions of patients positive for antinuclear antibody (ANA) and anti-SS-A (Ro) antibody or anti-SS-B (La) antibody were similar in the three groups. However, the low volume of saliva and the frequency of ANA in SS correlated with the degree of mononuclear cell infiltration in labial salivary glands. Our results suggested that HTLV-I infection is related to SS and that laboratory and clinical findings in SS closely correlate with the degree of mononuclear cell infiltration in the salivary glands.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695658     DOI: 10.1067/mlc.2000.103429

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

Review 1.  [Indications and options of new immune modulatory therapies for Sjögren's syndrome].

Authors:  E Feist; T Dörner; A Hansen
Journal:  Z Rheumatol       Date:  2007-12       Impact factor: 1.372

2.  Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.

Authors:  Ana Karina Ferraz-Chaoui; Ajax Mercês Atta; Maria Luiza Sousa Atta; Bernardo Galvão-Castro; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 3.  Is Sjögren's syndrome a retroviral disease?

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2011-04-13       Impact factor: 5.156

4.  Human T-cell lymphotropic virus type I (HTLV-1) associated myelopathy and Sjögren's syndrome representing pulmonary nodular amyloidosis and multiple bullae: Report of an autopsy case.

Authors:  Tomoko Seguchi; Yuka Kyoraku; Kazuko Saita; Toshihiko Ihi; Miyuki Nagai; Yutaka Akiyama; Hiroshi Itoh; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2006-04-12       Impact factor: 4.064

Review 5.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 6.  Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review.

Authors:  Hui Yu; Futoshi Higa; Ichiro Yamadori; Satomi Yara; Yasushi Tanimoto; Shusaku Haranaga; Masao Tateyama; Jiro Fujita; Mitsune Tanimoto; Huiping Li
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 7.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

Review 8.  B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Yukinori Takagi; Yoshiko Takahashi; Yoshiro Horai; Yoshikazu Nakashima; Shuntaro Sato; Hirokazu Shiraishi; Tatsufumi Nakamura; Junya Fukuoka; Takashi Nakamura; Atsushi Kawakami
Journal:  BMC Musculoskelet Disord       Date:  2015-11-04       Impact factor: 2.362

Review 10.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.